Greenwich LifeSciences (GLSI) said Thursday that its board of directors has extended the lock-up period for shares owned by its directors, officers, and existing pre-IPO investors.
The biopharmaceutical company said it has extended the lockup until March 31, 2026, or roughly five and a half years after the company's IPO.
Officers, directors, and certain shareholders will be unable to sell their shares during the lock-up period, unless the board modifies it, the company said.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。